Adi Mor
Algemeen Directeur bij CHEMOMAB THERAPEUTICS LTD.
Vermogen: 18 723 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Adi Mor
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
Chemomab Ltd.
 Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel.
7
| Subsidiary | Biotechnology | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Adi Mor via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder General Counsel | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CHECK POINT SOFTWARE TECHNOLOGIES LTD. | Internet Software/Services | Corporate Officer/Principal | |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
| CASSAVA SCIENCES, INC. | Biotechnology | Director/Board Member | |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Pharmaceuticals: Major | President | |
Micropharma Ltd.
 Micropharma Ltd. Pharmaceuticals: MajorHealth Technology Micropharma Ltd. formulates, manufactures & sells functional food, neutraceuticals and pharmaceutical products. The company was founded by Satya Prakash in 2002 and is headquartered in North Vancouver, Canada. | Pharmaceuticals: Major | Founder | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Private Equity Investor | |
| McGill University | College/University | Doctorate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Doctorate Degree Graduate Degree | |
| Technion-Israel Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| The Hebrew University of Jerusalem | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree | |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MY SIZE, INC. | Internet Software/Services | Director/Board Member Director/Board Member | |
Biocell Pty Ltd.
 Biocell Pty Ltd. Medical/Nursing ServicesHealth Services Part of Life Corp. Ltd., Biocell Pty Ltd. is an Australian company that operates a stem cell bank. The company is based in Melbourne, Australia. Biocell was acquired by CyGenics Ltd. on November 07, 2005 for $0.39 million. | Medical/Nursing Services | Private Equity Investor | |
| Université Libre de Bruxelles | College/University | Doctorate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
American Society for Microbiology
 American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal | |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
T-Cubed Investment Management LLC
 T-Cubed Investment Management LLC Investment ManagersFinance T-Cubed Investment Management LLC is an independent hedge fund manager headquartered in Fort Lee, New Jersey. The firm manages the assets of financially sophisticated clients. | Investment Managers | Chief Investment Officer | |
| B COMMUNICATIONS LTD | Major Telecommunications | Director/Board Member | |
MicroBiome Therapeutics LLC
 MicroBiome Therapeutics LLC Pharmaceuticals: MajorHealth Technology MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Hairstetics Ltd.
 Hairstetics Ltd. Medical SpecialtiesHealth Technology Hairstetics Ltd. engages in the development and manufacturing of hair restoration devices. The company was founded by Moshe Lapidoth, Ran Koronowski, Boaz Shenhav and Dvir Keren in 2010 and is headquartered in Omer, Israel. | Medical Specialties | Director/Board Member | |
| OUTLOOK THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
OurCrowd Management Ltd.
 OurCrowd Management Ltd. Investment ManagersFinance OurCrowd Management Ltd (OurCrowd Management) is a venture capital firm and equity based crowdfunding platform founded in 2013 by Jonathan Medved and Steven Blumgart. The firm is headquartered in Jerusalem, Israel. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
SmartZyme Biopharma, Inc.
 SmartZyme Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services SmartZyme Biopharma, Inc. provides platform for protein design and engineering in accordance with industry required specifications. The company was founded by David Baram and Shilo Ben Zeev in 2013 and is headquartered in Ness Ziona, Israel. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Lodo Therapeutics Corp.
 Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Joy Ventures
 Joy Ventures Investment ManagersFinance Joy Ventures (Joy Ventures) is a venture capital firm founded in 1900. The firm is headquartered in Herzeliya, Israel. | Investment Managers | Founder | |
| FINCH THERAPEUTICS GROUP, INC. | Medical/Nursing Services | Corporate Officer/Principal | |
ImmunoBrain Checkpoint Ltd.
 ImmunoBrain Checkpoint Ltd. BiotechnologyHealth Technology ImmunoBrain Checkpoint Ltd. engages in the development of neuroprotective immune therapies for neurodegenerative diseases. The company was founded by Michal Schwartz and Nathan Hevrony in 2015 and is headquartered in Ness Ziona, Israel. | Biotechnology | Private Equity Investor | |
| PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
AxoSim, Inc.
 AxoSim, Inc. Packaged SoftwareTechnology Services Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA. | Packaged Software | Chairman Chairman | |
| PALISADE BIO, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Orasis Pharmaceuticals Ltd.
 Orasis Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Orasis Pharmaceuticals Ltd. operates as a clinical stage pharmaceutical company. It develops eye drops for the treatment of presbyopia as an alternative to reading glasses. The company was founded in 2015 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| GAIN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Clinical Regulatory Services LLC | Founder | ||
Formula Pharmaceuticals, Inc.
 Formula Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Formula Pharmaceuticals, Inc. develops immunotherapies to treat cancer. It offers chimeric antigen receptor technology. The company was founded by Maurits W. Geerlings and Giorgio Mosconi in 2009 and is headquartered in Berwyn, PA. | Packaged Software | General Counsel | |
| ISPAC 1 LTD. | Financial Conglomerates | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 27 |
| Israël | 18 |
| Canada | 3 |
| Australië | 2 |
| België | 2 |
Sectoraal
| Health Technology | 24 |
| Technology Services | 6 |
| Consumer Services | 6 |
| Finance | 6 |
| Commercial Services | 5 |
Operationeel
| Director/Board Member | 126 |
| Corporate Officer/Principal | 50 |
| Independent Dir/Board Member | 30 |
| Chief Tech/Sci/R&D Officer | 25 |
| Private Equity Investor | 23 |
Sterkste connecties
| Insiders | |
|---|---|
| Stephen P. Squinto | 40 |
| David Ben-Ami | 30 |
| Nissim Darvish | 27 |
| Neil Cohen | 25 |
| Dale Pfost | 22 |
| Claude Nicaise | 16 |
| Donald Marvin | 15 |
| Efrat Makov | 15 |
| David Weiner | 14 |
| Nissim Mashiach | 11 |
| Arnon Aharon | 11 |
| Jason Camm | 11 |
| Jill Quigley | 11 |
| Alan Moses | 11 |
| Bryan Jennings | 10 |
